• Rhelion Life Sciences settled $100,000 of debt owed to an arm's-length creditor effective October 26, 2026.
• The settlement covered a prior Filament obligation through issuance of 3,333,333 common shares at a deemed price of $0.03 per share.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rhelion Life Sciences Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202611020737NEWSFILECNPR____20261102_322020_1) on November 02, 2026, and is solely responsible for the information contained therein.